Abstract
Hispidulin, a polyphenolic flavonoid extracted from the traditional Chinese medicinal plant S involucrata, exhibits anti-tumor effects in a wide array of human cancer cells, mainly through growth inhibition, apoptosis induction and cell cycle arrest. However, its precise anticancer mechanisms remain unclear. In this study, we investigated the molecular mechanisms that contribute to hispidulin-induced apoptosis of human clear-cell renal cell carcinoma (ccRCC) lines Caki-2 and ACHN. Hispidulin (10, 20 μmol/L) decreased the viability of ccRCC cells in dose- and time-dependent manners without affecting that of normal tubular epithelial cells. Moreover, hispidulin treatment dose-dependently increased the levels of cleaved caspase-8 and caspase-9, but the inhibitors of caspase-8 and caspase-9 only partly abrogated hispidulin-induced apoptosis, suggesting that hispidulin triggered apoptosis via both extrinsic and intrinsic pathways. Moreover, hispidulin treatment significantly inhibited the activity of sphingosine kinase 1 (SphK1) and consequently promoted ceramide accumulation, thus leading to apoptosis of the cancer cells, whereas pretreatment with K6PC-5, an activator of SphK1, or overexpression of SphK1 significantly attenuated the anti-proliferative and pro-apoptotic effects of hispidulin. In addition, hispidulin treatment dose-dependently activated ROS/JNK signaling and led to cell apoptosis. We further demonstrated in Caki-2 xenograft nude mice that injection of hispidulin (20, 40 mg·kg−1·d−1, ip) dose-dependently suppressed tumor growth accompanied by decreased SphK1 activity and increased ceramide accumulation in tumor tissues. Our findings reveal a new explanation for the anti-tumor mechanisms of hispidulin, and suggest that SphK1 and ceramide may serve as potential therapeutic targets for the treatment of ccRCC.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Change history
07 September 2021
A Correction to this paper has been published: https://doi.org/10.1038/s41401-021-00731-3
References
Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D . Global cancer statistics. CA Cancer J Clin 2011; 61: 69–90.
Rini BI, Campbell SC, Escudier B . Renal cell carcinoma. Lancet 2009; 373: 1119–32.
Antonelli A, Cozzoli A, Zani D, Zanotelli T, Nicolai M, Cunico SC, et al. The follow-up management of non-metastatic renal cell carcinoma: definition of a surveillance protocol. BJU Int 2007; 99: 296–300.
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, et al. Sorafenib in advanced clear-cell renal-cell carcinoma. New Engl J Med 2007; 356: 125–34.
Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, et al. Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. New Engl J Med 2007; 356: 2271–81.
Motzer RJ, Hutson TE, Tomczak P, Michaelson MD, Bukowski RM, Rixe O, et al. Sunitinib versus interferon alfa in metastatic renal-cell carcinoma. New Engl J Med 2007; 356: 115–24.
Motzer RJ, Escudier B, Oudard S, Hutson TE, Porta C, Bracarda S, et al. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial. Lancet 2008; 372: 449–56.
Adan-Gokbulut A, Kartal-Yandim M, Iskender G, Baran Y . Novel agents targeting bioactive sphingolipids for the treatment of cancer. Curr Med Chem 2013; 20: 108–22.
Cuvillier O, Ader I, Bouquerel P, Brizuela L, Malavaud B, Mazerolles C, et al. Activation of sphingosine kinase-1 in cancer: implications for therapeutic targeting. Curr Mol Pharmacol 2010; 3: 53–65.
Maceyka M, Harikumar KB, Milstien S, Spiegel S . Sphingosine-1-phosphate signaling and its role in disease. Trends Cell Biol 2012; 22: 50–60.
Zhang Y, Wang Y, Wan Z, Liu S, Cao Y, Zeng Z . Sphingosine kinase 1 and cancer: a systematic review and meta-analysis. PLoS One 2014; 9: e90362.
Salama MF, Carroll B, Adada M, Pulkoski-Gross M, Hannun YA, Obeid LM . A novel role of sphingosine kinase-1 in the invasion and angiogenesis of VHL mutant clear cell renal cell carcinoma. FASEB J 2015; 29: 2803–13.
Gao H, Deng L . Sphingosine kinase-1 activation causes acquired resistance against Sunitinib in renal cell carcinoma cells. Cell Biochem Biophys 2014; 68: 419–25.
Alshaker H, Sauer L, Monteil D, Ottaviani S, Srivats S, Bohler T, et al. Therapeutic potential of targeting SK1 in human cancers. Adv Cancer Res 2013; 117: 143–200.
Way TD, Lee JC, Kuo DH, Fan LL, Huang CH, Lin HY, et al. Inhibition of epidermal growth factor receptor signaling by Saussurea involucrata, a rare traditional Chinese medicinal herb, in human hormone-resistant prostate cancer PC-3 cells. J Agric Food Chem 2010; 58: 3356–65.
Yin Y, Gong FY, Wu XX, Sun Y, Li YH, Chen T, et al. Anti-inflammatory and immunosuppressive effect of flavones isolated from Artemisia vestita. J Ethnopharmacol 2008; 120: 1–6.
Kavvadias D, Sand P, Youdim KA, Qaiser MZ, Rice-Evans C, Baur R, et al. The flavone hispidulin, a benzodiazepine receptor ligand with positive allosteric properties, traverses the blood-brain barrier and exhibits anticonvulsive effects. Br J Pharmacol 2004; 142: 811–20.
Tan RX, Lu H, Wolfender JL, Yu TT, Zheng WF, Yang L, et al. Mono- and sesquiterpenes and antifungal constituents from Artemisia species. Planta Medica 1999; 65: 64–7.
Nagao T, Abe F, Kinjo J, Okabe H . Antiproliferative constituents in plants 10. Flavones from the leaves of Lantana montevidensis Briq and consideration of structure-activity relationship. Biol Pharm Bull 2002; 25: 875–9.
Chen YT, Zheng RL, Jia ZJ, Ju Y . Flavonoids as superoxide scavengers and antioxidants. Free Radic Biol Med 1990; 9: 19–21.
Bourdillat B, Delautier D, Labat C, Benveniste J, Potier P, Brink C . Mechanism of action of hispidulin, a natural flavone, on human platelets. Prog Clin Biol Res 1988; 280: 211–4.
Niu X, Chen J, Wang P, Zhou H, Li S, Zhang M . The effects of hispidulin on bupivacaine-induced neurotoxicity: role of AMPK signaling pathway. Cell Biochem Biophys 2014; 70: 241–9.
Zhou R, Wang Z, Ma C . Hispidulin exerts anti-osteoporotic activity in ovariectomized mice via activating AMPK signaling pathway. Cell Biochem Biophys 2014; 69: 311–7.
Nepal M, Choi HJ, Choi BY, Yang MS, Chae JI, Li L, et al. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-kappaB and NFATc1 pathways. Eur J Pharmacol 2013; 715: 96–104.
Yang JM, Hung CM, Fu CN, Lee JC, Huang CH, Yang MH, et al. Hispidulin sensitizes human ovarian cancer cells to TRAIL-induced apoptosis by AMPK activation leading to Mcl-1 block in translation. J Agric Food Chem 2010; 58: 10020–6.
Lin YC, Hung CM, Tsai JC, Lee JC, Chen YL, Wei CW, et al. Hispidulin potently inhibits human glioblastoma multiforme cells through activation of AMP-activated protein kinase (AMPK). J Agric Food Chem 2010; 58: 9511–7.
He L, Wu Y, Lin L, Wang J, Chen Y, Yi Z, et al. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway. Cancer Sci 2011; 102: 219–25.
Yu CY, Su KY, Lee PL, Jhan JY, Tsao PH, Chan DC, et al. Potential therapeutic role of hispidulin in gastric cancer through induction of apoptosis via NAG-1 signaling. Evid Based Complement Alternat Med 2013; 2013: 518301.
Gao H, Wang H, Peng J . Hispidulin induces apoptosis through mitochondrial dysfunction and inhibition of P13k/Akt signalling pathway in HepG2 cancer cells. Cell Biochem Biophys 2014; 69: 27–34.
Gao H, Liu Y, Li K, Wu T, Peng J, Jing F . Hispidulin induces mitochondrial apoptosis in acute myeloid leukemia cells by targeting extracellular matrix metalloproteinase inducer. Am J Transl Res 2016; 8: 1115–32.
Zheng B, Mao JH, Li XQ, Qian L, Zhu H, Gu DH, et al. Over-expression of DNA-PKcs in renal cell carcinoma regulates mTORC2 activation, HIF-2alpha expression and cell proliferation. Sci Rep 2016; 6: 29415.
Pan XD, Gu DH, Mao JH, Zhu H, Chen X, Zheng B, et al. Concurrent inhibition of mTORC1 and mTORC2 by WYE-687 inhibits renal cell carcinoma cell growth in vitro and in vivo. PLoS One 2017; 12: e0172555.
Liu SQ, Su YJ, Qin MB, Mao YB, Huang JA, Tang GD . Sphingosine kinase 1 promotes tumor progression and confers malignancy phenotypes of colon cancer by regulating the focal adhesion kinase pathway and adhesion molecules. Int J Oncol 2013; 42: 617–26.
Lee CJ, Han JS, Seo CY, Park TH, Kwon HC, Jeong JS, et al. Pioglitazone, a synthetic ligand for PPARgamma, induces apoptosis in RB-deficient human colorectal cancer cells. Apoptosis 2006; 11: 401–11.
Yao C, Wu S, Li D, Ding H, Wang Z, Yang Y, et al. Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro. Mol Oncol 2012; 6: 392–404.
Shakor AB, Atia M, Ismail IA, Alshehri A, El-Refaey H, Kwiatkowska K, et al. Curcumin induces apoptosis of multidrug-resistant human leukemia HL60 cells by complex pathways leading to ceramide accumulation. Biochim Biophys Acta 2014; 1841: 1672–82.
Kim KP, Shin KO, Park K, Yun HJ, Mann S, Lee YM, et al. Vitamin C stimulates epidermal ceramide production by regulating its metabolic enzymes. Biomol Ther (Seoul) 2015; 23: 525–30.
Han Y, Yang X, Zhao N, Peng J, Gao H, Qiu X . Alpinumisoflavone induces apoptosis in esophageal squamous cell carcinoma by modulating miR-370/PIM1 signaling. Am J Cancer Res 2016; 6: 2755–71.
Chen L, Ren J, Yang L, Li Y, Fu J, Li Y, et al. Stearoyl-CoA desaturase-1 mediated cell apoptosis in colorectal cancer by promoting ceramide synthesis. Sci Rep 2016; 6: 19665.
Wang Y, Liu W, He X, Fei Z . Hispidulin enhances the anti-tumor effects of temozolomide in glioblastoma by activating AMPK. Cell Biochem Biophys 2015; 71: 701–6.
Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, et al. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1alpha. Exp Cell Res 2015; 332: 236–46.
Gao H, Jiang Q, Han Y, Peng J, Wang C . Hispidulin potentiates the antitumor effect of sunitinib against human renal cell carcinoma in laboratory models. Cell Biochem Biophys 2015; 71: 757–64.
Liu YL, Ho DK, Cassady JM, Cook VM, Baird WM . Isolation of potential cancer chemopreventive agents from Eriodictyon californicum. J Nat Prod 1992; 55: 357–63.
Scoparo CT, Valdameri G, Worfel PR, Guterres FA, Martinez GR, Winnischofer SM, et al. Dual properties of hispidulin: antiproliferative effects on HepG2 cancer cells and selective inhibition of ABCG2 transport activity. Mol Cell Biochem 2015; 409: 123–33.
Wu J, Ru NY, Zhang Y, Li Y, Wei D, Ren Z, et al. HAb18G/CD147 promotes epithelial-mesenchymal transition through TGF-beta signaling and is transcriptionally regulated by Slug. Oncogene 2011; 30: 4410–27.
Safarzadeh E, Sandoghchian Shotorbani S, Baradaran B . Herbal medicine as inducers of apoptosis in cancer treatment. Adv Pharm Bull 2014; 4: 421–7.
Dias N, Bailly C . Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 2005; 70: 1–12.
Mullen TD, Obeid LM . Ceramide and apoptosis: exploring the enigmatic connections between sphingolipid metabolism and programmed cell death. Anticancer Agents Med Chem 2012; 12: 340–63.
Scarlatti F, Sala G, Somenzi G, Signorelli P, Sacchi N, Ghidoni R . Resveratrol induces growth inhibition and apoptosis in metastatic breast cancer cells via de novo ceramide signaling. FASEB J 2003; 17: 2339–41.
Kartal M, Saydam G, Sahin F, Baran Y . Resveratrol triggers apoptosis through regulating ceramide metabolizing genes in human K562 chronic myeloid leukemia cells. Nutr Cancer 2011; 63: 637–44.
Yun SH, Park ES, Shin SW, Na YW, Han JY, Jeong JS, et al. Stichoposide C induces apoptosis through the generation of ceramide in leukemia and colorectal cancer cells and shows in vivo antitumor activity. Clin Cancer Res 2012; 18: 5934–48.
Pyne NJ, Tonelli F, Lim KG, Long JS, Edwards J, Pyne S . Sphingosine 1-phosphate signalling in cancer. Biochem Soc Trans 2012; 40: 94–100.
Gstalder C, Ader I, Cuvillier O . FTY720 (Fingolimod) inhibits HIF1 and HIF2 signaling, promotes vascular remodeling, and chemosensitizes in renal cell carcinoma animal model. Mol Cancer Ther 2016; 15: 2465–74.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (No 31470570 and 81603337), the Chongqing Natural Science Foundation (No cstc2014jcyjA80013), the Science Foundation of Chongqing Education Commission (No kj1400534), and the Project of Clinical Medicine+X, Department of Medicine, Qingdao University (2017M38).
Author information
Authors and Affiliations
Corresponding authors
About this article
Cite this article
Gao, H., Gao, Mq., Peng, Jj. et al. RETRACTED ARTICLE: Hispidulin mediates apoptosis in human renal cell carcinoma by inducing ceramide accumulation. Acta Pharmacol Sin 38, 1618–1631 (2017). https://doi.org/10.1038/aps.2017.154
Received:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/aps.2017.154
Keywords
This article is cited by
-
RETRACTED ARTICLE: Endoplasmic reticulum stress triggers Xanthoangelol-induced protective autophagy via activation of JNK/c-Jun Axis in hepatocellular carcinoma
Journal of Experimental & Clinical Cancer Research (2019)
-
Quantitative analysis, pharmacokinetics and metabolomics study for the comprehensive characterization of the salt-processing mechanism of Psoraleae Fructus
Scientific Reports (2019)
-
RETRACTED ARTICLE: Hispidulin induces ER stress-mediated apoptosis in human hepatocellular carcinoma cells in vitro and in vivo by activating AMPK signaling pathway
Acta Pharmacologica Sinica (2019)
-
Targeting the transcription factor receptor LXR to treat clear cell renal cell carcinoma: agonist or inverse agonist?
Cell Death & Disease (2019)
-
RETRACTED ARTICLE: Soyasapogenol B exhibits anti-growth and anti-metastatic activities in clear cell renal cell carcinoma
Naunyn-Schmiedeberg's Archives of Pharmacology (2019)
